Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes.
Debra M LundquistRachel B JimenezSienna M DurbinNora HorickMegan HealyAndrew E JohnsonViola BameVirginia CapassoCasandra McIntyreBarbara CashavellyDejan JuricRyan D NippPublished in: JCO oncology practice (2023)
This study found that RMH prognosis score could identify patients at risk for decreased survival, shorter time on trial, and greater use of health care services. The findings underscore the need to develop supportive care interventions targeting EP-CT participants' distinct needs.
Keyphrases
- healthcare
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- phase ii
- study protocol
- primary care
- chronic kidney disease
- phase iii
- palliative care
- affordable care act
- peritoneal dialysis
- mental health
- open label
- quality improvement
- pain management
- contrast enhanced
- patient reported outcomes
- cancer therapy
- social media
- health insurance
- placebo controlled